MACUMIRA: A NEW DAY IN DRY AMD TREATMENT
MacuMira is a clinically validated treatment option approved by Health Canada, offering hope for individuals looking to potentially slow the progression of dry AMD and enhance their vision.
Reach out to us to schedule your appointment today and find out if MacuMira is the right choice for you.
UNDERSTANDING DRY AGE-RELATED MACULAR DEGENERATION
Age-related macular degeneration (AMD) is an eye disease that damages the macula, a part of the retina responsible for sharp, central vision, leading to blurred or lost central vision. It is a common cause of vision loss in older adults, particularly those over 50.
AMD has two forms: Dry AMD, the more common type, involves thinning of the macula and the accumulation of deposits (drusen). Wet AMD is a less common but more severe form where abnormal blood vessels grow under the retina and leak fluid and blood, causing rapid vision loss.
​
Some symptoms you may experience:
-
Blurry or fuzzy central vision.
-
Wavy or distorted straight lines.
-
A blank spot or dark area in your central vision.
-
Difficulty recognizing face
During an eye exam, your eye care provider can spot early changes like the presence of drusen—yellow deposits under the retina—or signs of macular thinning. These indicators may show up even before any symptoms arise. Early detection is key, as it enables timely monitoring and the opportunity to discuss treatment options, including MacuMira.
Benefits of MacuMira
MacuMira is the first clinically proven, noninvasive treatment for dry AMD that can actually improve vision. Safe and painless, MacuMira has potential to:
MacuMira has been proven safe and effective in early clinical trials. Results have been promising, and more extensive long-term clinical trials are in the works to better understand the duration of benefit. The MacuMira clinical trial, published in the International Journal of Retina and Vitreous, found the following:
How does Macumira help with vision loss?
MacuMira delivers gentle microcurrent energy through your eyelids that stimulates the retina. This is designed to help support your visual function and slow the progression of dry AMD by enhancing cellular energy, clear waste products like drusen from the macula, and supports photoreceptor cells, which are crucial for vision; boosting the function and health of retinal cells.
It is important to note that MacuMira is NOT a cure. However, it may help improve functional vision and slow progressive vision loss in people with dry AMD and introduces a valuable complementary therapy to traditional approaches, including taking AREDS 2 supplements to support macular health.
​​
What to expect during a treatment?
-
MacuMira treatment isn’t painful, and there are no needles or drugs involved. It is completely noninvasive.
-
During the treatment, you will be seated or reclined while a headset is placed over your closed eyes.
-
Each Macumira session typically lasts about 32 minutes, delivering microcurrent stimulation to the retina.
-
Some patients experience a mild tingling sensation or brief patterns of light during the session. These are known as phosphenes and are a completely normal response to the stimulation.
-
After the session, you can continue with your day as normal with no downtime or restrictions.
-
Recommend treatment protocol begins with a 'loading phase' involving 4 treatments over a roughly 10 day period, followed by maintenance treatments as necessary.
